-
[Nature Communications] Escalating Transmissibility of Severe Fever with Thrombocytopenia Syndrome in a High-Endemic Region of China
2026-05-13
-
[Nature Communications] A biomimetic nanodisc system selectively activates type I interferons by nonclassical STING pathway for cancer immunotherapy
2026-04-09
-
[Science Advances] Cold Atmospheric Plasma Engineered Nanovaccine with Spatiotemporal Sequential Immunization Reprograms Antitumor Immunity
2026-04-08
-
[ACS Nano] Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection
2026-03-31
-
[Cell Reports Medicine] A bispecific nanobody‒drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer
2026-03-19
-
[Nature Communications] A selective enrichment and specific probe terminal mediated strategy for highly sensitive detection of microRNAs
2026-03-17
-
[Nature Communications] XA-Novo: high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures
2026-03-14
-
[Nature Communications] Engineering NIR-II carbon dots through aniline extension with graphene and nitrogen enrichment for hepatobiliary theranostics
2026-03-05
-
[Nature Communications] Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma
2026-03-03
-
[Science Bulletin] Immunogenicity and Safety of an Escherichia coli-produced 9-valent HPV Vaccine in Adolescents Aged 9 to 17 Compared with Young Women
2026-02-28